Your session is about to expire
← Back to Search
EDP1815 for Atopic Dermatitis
Study Summary
This trial will test whether EDP1815 is safe and effective for treating atopic dermatitis. Different doses will be compared, as well as once-daily and twice-daily administration.
- Atopic Dermatitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 249 Patients • NCT04603027Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is it possible for me to join this research project?
"This medical trial is inviting 405 people aged 18 to 75 who have eczema and satisfy additional conditions, such as written consent, a 6 month history of atopic dermatitis (AD), an Investigator's Global Assessment (IGA) score between 2-4 on the vIGA scale, a minimum Body Surface Area (BSA) of 5%, an Eczema Area Severity Index (EASI) above 6, agreement to use emollients, and contraception requirements."
Has the Food and Drug Administration given its stamp of approval to EDP1815?
"There is some evidence indicating that EDP1815 is safe, resulting in it receiving a score of 2. Given this trial's Phase 2 designation, there are no clinical data supporting the drug's efficacy."
Are there still open slots for those interested in participating in this experiment?
"As evidenced on clinicaltrials.gov, this research endeavour is no longer actively seeking participants. Initially posted in January of 2022, the most recent update to the trial's information was November 3rd of that same year. While not enrolling any new patients currently, there are numerous other medical trials which do require more volunteers at present moment."
Is the age criterion for admission to this research trial above 25 years old?
"This medical trial is open to all individuals falling within the age range of 18-75. By comparison, there are 102 clinical trials for those younger than eighteen and 166 available for seniors over 65."
How many sites are involved in the implementation of this trial?
"36 clinics across the United States are currently enrolling patients for this study. Ann Arbor, Concord and Fountain Valley are three of these locations; you can find a full list on our website. Choosing the clinic closest to your residence is highly encouraged to alleviate travel burdens."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger